Synthesis and Anticancer Activity of N-Aryl-5-substituted-1,3,4-oxadiazol-2-amine Analogues

被引：23

作者：

Ahsan, Mohamed Jawed ^{[1
]}

Sharma, Jyotika ^{[1
]}

Singh, Monika ^{[1
]}

Jadav, Surender Singh ^{[2
]}

Yasmin, Sabina ^{[2
]}

机构：

[1] Maharishi Arvind Coll Pharm, Dept Pharmaceut Chem, Jaipur 302023, Rajasthan, India

[2] Birla Inst Technol, Dept Pharmaceut Chem, Ranchi 835215, Bihar, India

来源：

BIOMED RESEARCH INTERNATIONAL | 2014年 / 2014卷

关键词：

MOLECULAR-PROPERTIES; DRUG; DISCOVERY;

D O I：

10.1155/2014/814984

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

In continuance of our search for anticancer agents, we report herein the synthesis and anticancer activity of some novel oxadiazole analogues. The compounds were screened for anticancer activity as per National Cancer Institute (NCI US) protocol on leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate, and breast cancers cell lines. N-(2,4-Dimethylphenyl)-5-(4-methoxyphenyl)-1,3,4- oxadiazol-2-amine (4s) showed maximum activity with mean growth percent (GP) of 62.61 and was found to be the most sensitive on MDA-MB-435 (melanoma), K-562 (leukemia), T-47D (breast cancer), and HCT-15 (colon cancer) cell lines with GP of 15.43, 18.22, 34.27, and 39.77, respectively. Maximum GP was observed on MDA-MB-435 (melanoma) cell line (GP = 6.82) by compound N-(2,4-dimethylphenyl)-5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-amine (4u).

引用

页数：9

共 50 条

[1] 5-Phenyl-1,3,4-oxadiazol-2-amine
Song, Man -Man
Wu, Kong -Li
Zhu, Lin
Zheng, Juan
Xu, Yan
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O3058 - +
[2] 5-(4-Methylphenyl)-1,3,4-oxadiazol-2-amine
Zheng, Juan
Li, Wen-juan
Song, Manman
Xu, Yan
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1668 - +
[3] 5-(2-Bromo-5-methoxyphenyl)-1,3,4-oxadiazol-2-amine
Yathirajan, H. S.
Bindya, S.
Ashalatha, B. V.
Narayana, B.
Bolte, Michael
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O4442 - O4443
[4] Crystal structure of 5-(furan-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine
Paswan, Santosh
Bharty, Manoj K.
Kumari, Sanyucta
Gupta, Sushi K.
Singh, Nand K.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2015, 71 : O880 - U584
[5] 5-(5'-Fluoro-2'-methoxybiphenyl-3-yl)-1,3,4-oxadiazol-2-amine
Usha, M. K.
Ramaprasad, G. C.
Kalluraya, Balakrishna
Kant, Rajni
Gupta, Vivek K.
Revannasiddaiah, D.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1788 - +
[6] Mn(II) assisted synthesis of N-phenyl-5-(pyridin-3-yl)-1,3,4-oxadiazol-2-amine and evaluation of its antiproliferative activity
Jaiswal, Shubham
Pandey, Shivendra Kumar
Minocha, Tarun
Chandra, S.
Bharty, M. K.
Yadav, S. K.
Kushwaha, D.
Butcher, R. J.
JOURNAL OF MOLECULAR STRUCTURE, 2023, 1281
[7] Synthesis and crystal structure of 5-((5-amino-2H-tetrazol-2-yl)methyl)-1,3,4-oxadiazol-2-amine
Zhu, Yingzhi
Yang, Feng
Zhou, Xinli
Lin, Qiuhan
Wang, Pengchen
Lu, Ming
MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 2021, 724 (01) : 38 - 46
[8] 5-((Methoxyimino){2-[(2-methylphenoxy)methyl]phenyl}methyl)-N-phenyl1,3,4-oxadiazol-2-amine
Sharma, Devinder K.
Shripanavar, Chetan S.
Anthal, Sumati
Gupta, Vivek K.
Kant, Rajni
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O357 - +
[9] Synthesis, Anticancer Activity and Molecular Docking Studies of Hybrid Benzimidazole-1,3,4-Oxadiazol-2-N-Alkyl/Aryl Amines
Katikireddy, Ramamurthy
Marri, Srinivas
Kakkerla, Ramu
Krishna, M. P. S. Murali
Gandamalla, Durgaiah
Reddy, Y. N.
POLYCYCLIC AROMATIC COMPOUNDS, 2022, 42 (09) : 5855 - 5869
[10] Synthesis, antibacterial and anticancer evaluation of 5-substituted (1,3,4-oxadiazol-2-yl)quinoline
Avijit Salahuddin
Mohammad Mazumder
Medicinal Chemistry Research, 2015, 24 : 2514 - 2528

← 1 2 3 4 5 →